Luye Pharma Group Ltd. (2186.HK)
HKD 2.08
(2.97%)
HKD 2.08
(2.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.59 Billion | 1.65 Billion | 182.37 Million | 1.03 Billion | 1.74 Billion | 1.04 Billion |
| Net Income | 700.1 Million | 669.76 Million | -74.55 Million | 942.17 Million | 1.77 Billion | 1.47 Billion |
| Depreciation & Amortization | 701.85 Million | 671.31 Million | 581.98 Million | 510.89 Million | 442.03 Million | 317.18 Million |
| Deferred income taxes | - | - | -311.91 Million | -505.88 Million | -422.49 Million | -411.5 Million |
| Stock-based compensation | 20.64 Million | 25.44 Million | 50.07 Million | 51.25 Million | 65.78 Million | 31.33 Million |
| Change in working capital | 397.98 Million | 319.79 Million | -418.08 Million | -300.32 Million | -289.63 Million | -486.15 Million |
| Other non-cash items | 564.72 Million | -32.51 Million | 354.96 Million | 335.68 Million | 178.66 Million | 121.25 Million |
| Investing Cash Flow | -1.41 Billion | -1.65 Billion | -3.43 Billion | 138.19 Million | -2.69 Billion | -2.99 Billion |
| Investments in PPE | -1.16 Billion | -1.16 Billion | -1.54 Billion | -1.51 Billion | -3.22 Billion | -2.48 Billion |
| Acquisitions | -1.38 Billion | - | -808.51 Million | -450.78 Million | -2.08 Billion | -1.65 Billion |
| Investment purchases | -1.62 Billion | -3.48 Billion | -3.97 Billion | -2.85 Billion | -3.07 Billion | -3.95 Billion |
| Sales/Maturities of investments | 2.59 Billion | 2.89 Billion | 1.91 Billion | 4.15 Billion | 3.39 Billion | 3.32 Billion |
| Other Investing Activities | 4.04 Million | 91.8 Million | 970.73 Million | 814.24 Million | 2.29 Billion | 1.77 Billion |
| Financing Cash Flow | 841.59 Million | 54.14 Million | 1.87 Billion | 253.98 Million | 1.6 Billion | 2.4 Billion |
| Debt repayment | -454.45 Million | -8.3 Billion | -7.53 Billion | -5.89 Billion | -6.73 Billion | -3.27 Billion |
| Dividends payments | - | - | - | -175.48 Million | -376.77 Million | -289.71 Million |
| Common Stock Repurchased | - | - | - | -77.96 Million | -8.77 Million | -21.6 Million |
| Common Stock Issuance | 922.96 Million | 189.15 Million | 1.04 Billion | 7.32 Billion | 8.82 Billion | 1.64 Million |
| Other Financing Activities | 425.63 Million | 8.16 Billion | 8.37 Billion | -922.61 Million | -97.23 Million | -560.81 Million |
| Accounts receivables | -570.84 Million | -18.76 Million | -211.76 Million | 144.99 Million | -166.61 Million | -120.06 Million |
| Accounts payables | - | 18.76 Million | 211.76 Million | -144.99 Million | 166.61 Million | - |
| Inventory | -54.92 Million | -26.59 Million | -134.04 Million | 4.87 Million | -29.01 Million | -165.25 Million |
| Other working capital | 891.37 Million | 346.38 Million | -284.04 Million | -305.2 Million | -260.62 Million | -320.89 Million |
| Cash at beginning of period | 2.32 Billion | 2.43 Billion | 3.86 Billion | 2.32 Billion | 1.67 Billion | 1.26 Billion |
| Cash at end of period | 3.23 Billion | 2.32 Billion | 2.43 Billion | 3.86 Billion | 2.32 Billion | 1.67 Billion |
| Capital Expenditure | -1.16 Billion | -1.16 Billion | -1.54 Billion | -1.51 Billion | -3.22 Billion | -2.48 Billion |
| Effect of forex changes on cash | -103.59 Million | -164.14 Million | -52.36 Million | 112.4 Million | -7.53 Million | -45.49 Million |
| Net cash flow / Change in cash | 915.23 Million | -114.51 Million | -1.42 Billion | 1.53 Billion | 652.58 Million | 406.99 Million |
| Free Cash Flow | 430.22 Million | 490.13 Million | -1.35 Billion | -486.43 Million | -1.47 Billion | -1.43 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 193.91 Million | 193.91 Million | 700.1 Million | 191.31 Million | 191.31 Million | 74.98 Million |
| Depreciation & Amortization | 174.15 Million | 174.15 Million | 701.85 Million | 185.21 Million | 181.15 Million | 165.71 Million |
| Deferred income taxes | - | - | - | - | - | -1.12 Billion |
| Stock-based compensation | 5.14 Million | 5.14 Million | 20.64 Million | 5.2 Million | 5.2 Million | 5.11 Million |
| Change in working capital | -607.62 Million | -607.62 Million | 397.98 Million | 39.73 Million | 39.73 Million | 93.07 Million |
| Other non-cash items | 37.2 Million | 37.2 Million | 564.72 Million | 31.42 Million | 35.48 Million | 5.96 Million |
| Investing Cash Flow | -252.65 Million | -252.65 Million | -1.41 Billion | -670.11 Million | -670.11 Million | -39 Million |
| Investments in PPE | - | - | -1.16 Billion | -316.32 Million | -316.32 Million | -544.21 Million |
| Acquisitions | - | - | -1.38 Billion | - | - | 109.7 Thousand |
| Investment purchases | - | - | -1.62 Billion | - | - | -218.71 Million |
| Sales/Maturities of investments | - | - | 2.59 Billion | - | - | 627.67 Million |
| Other Investing Activities | -252.65 Million | -252.65 Million | 4.04 Million | -353.79 Million | -353.79 Million | -39 Million |
| Financing Cash Flow | 490.19 Million | 490.19 Million | 841.59 Million | -340.67 Million | -340.67 Million | 761.47 Million |
| Debt repayment | - | - | -454.45 Million | - | - | -561.83 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 922.96 Million | - | - | 1.04 Billion |
| Other Financing Activities | 490.19 Million | 490.19 Million | 425.63 Million | -340.67 Million | -340.67 Million | 761.47 Million |
| Accounts receivables | -111.35 Million | -111.35 Million | -570.84 Million | -83.89 Million | -83.89 Million | -201.52 Million |
| Accounts payables | - | - | - | - | - | 118.97 Million |
| Inventory | 6.15 Million | 6.15 Million | -54.92 Million | -12.12 Million | -12.12 Million | -15.33 Million |
| Other working capital | -502.42 Million | -502.42 Million | 891.37 Million | 135.75 Million | 135.75 Million | 309.93 Million |
| Cash at beginning of period | - | - | 2.32 Billion | - | - | 2.64 Billion |
| Cash at end of period | 50.33 Million | 50.33 Million | 3.23 Billion | -616.89 Million | -616.89 Million | 4.82 Billion |
| Capital Expenditure | - | - | -1.16 Billion | -316.32 Million | -316.32 Million | -544.21 Million |
| Effect of forex changes on cash | 9.99 Million | 9.99 Million | -103.59 Million | -58.98 Million | -58.98 Million | 7.18 Million |
| Net cash flow / Change in cash | 50.33 Million | 50.33 Million | 915.23 Million | -616.89 Million | -616.89 Million | 2.18 Billion |
| Free Cash Flow | -197.2 Million | -197.2 Million | 430.22 Million | 136.55 Million | 136.55 Million | -199.35 Million |
1801
0QW7
CCB
603317
DUFRY
0I4X